1-2 of 2 results for subject:Finance
Librarians' tools
- Search time
- 0.181 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Finance
- We searched for
- subject_t:Finance OR subject_ses:91257
Type
House
Session
Year
Department
Member
Primary member
More
Winterton, Nicholas (2)
Answering member
Legislative stage
Legislation
Subject
More
Prostate cancer (2)
Publisher
To ask the Secretary of State for Health, what research his Department is funding to develop a more reliable diagnostic test for prostate cancer. - Inc ref to 14 October 2004, 425 c356W.
To ask the Secretary of State for Health, what research his Department is funding to develop a more reliable diagnostic test for prostate cancer. - Inc ref to 14 October 2004, 425 c356W.
Asked by
Nicholas Winterton
(Conservative)
Answered by
Melanie Johnson
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
11 January 2005
For answer on
20 January 2005
Answered on
20 January 2005
Subjects
Finance; Screening; Research; Prostate cancer
Date
20 January 2005
Reference
208407; 429 c1124W
House
House of Commons
To ask the Secretary of State for Health, what specific healthcare strategies he has set for the detection and treatment of (a) prostate, (b) lung, (c) bowel and (d) testicular cancer in men; and if he will make a statement. - Inc figures.
To ask the Secretary of State for Health, what specific healthcare strategies he has set for the detection and treatment of (a) prostate, (b) lung, (c) bowel and (d) testicular cancer in men; and if he will make a statement. - Inc figures.
Asked by
Nicholas Winterton
(Conservative)
Answered by
Hazel Blears
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
5 June 2003
For answer on
13 June 2003
Answered on
13 June 2003
Sir Nicholas Winterton: To ask the Secretary of State for Health what specific health care strategies he has set for the detection
and treatment of (a) prostate, (b) lung, (c) bowel and (d) testicular cancer in men; and if he will make a statement. [118563]
Ms Blears: We are taking action in several areas to improve the detection and treatment of prostate, lung, bowel and testicular
cancer: The national health service prostate cancer programme sets out the Government's approach to improving prostate cancer
services including the publication of the prostate cancer risk management programme in July 2001 and a commitment to introducing a
prostate cancer screening programme if, and when, screening and treatment techniques have developed sufficiently. There has been
targeted investment in lung cancer services. An additional £10 million was made available from 1999 to improve lung cancer services.
This money is being used to help improve access to services, enhance the quality of treatment and to bring down waiting times for
treatment for lung cancer. From 2002-03, this money was placed in baseline allocations. The national cancer director launched the
NHS bowel cancer programme on 4 February 2003. This programme will translate into action the Government's commitment to continue to
improve services for bowel cancer patients and to introduce a national screening programme for bowel cancer. There are already
specialist NHS services for the management of men with testicular cancer and outcomes are generally good with the vast majority of
patients being cured. Men should be aware of any unusual changes in their testicles and consult doctors early in order to ensure the
maximum chance of a cure. That is why we have collaborated with Cancer Research UK in the production of a testicular self-awareness
leaflet "Testicular Cancer: Spot The Symptoms Early", which is widely available. The National Institute for Clinical Excellence
(NICE) has published guidance on the use of new generation chemotherapy drugs benefiting around 5,000 lung cancer patients and 7,000
bowel cancer patients each year. NICE is currently preparing guidance on the use of a new drug, Iressa, for the treatment of lung
cancer. Last year, NICE published "Improving Outcomes Guidance" (IOG) on the organisation and delivery of services for people with
urological cancers, including prostate and testicular cancer. Local NHS organisations are currently developing action plans for
implementing the guidance. NICE is currently updating the 1997 IOG for bowel cancer services. The updated guidance is due to be
published later this summer. IOG for lung cancer services was published in 1998. NICE is now developing clinical guidelines for the
diagnosis and management of lung cancer, which are due to be published in March 2004.
We are determined to improve cancer services for all patients, including those with prostate, lung, bowel and testicular cancers.
That is why the Cancer Plan is being backed by the biggest ever increase in funding for cancer services. Compared to 2000-01, there
will be an additional £570 million a year in 2003-04.
Subjects
Cancer; Diagnosis; Finance; Diseases; Medical treatments; Men; Screening; Prostate cancer; Lung cancer; Testicular cancer; Bowel cancer
Date
13 June 2003
Reference
118563; 406 c1121W;406 c1123W
House
House of Commons